PAINREFORM LTD., now PRF Technologies Ltd., has historically focused on reformulating therapies for extended pain relief with an emphasis on reduced opioid use but has recently diversified into the clean energy sector via the acquisition of DeepSolar, an AI-based solar analytics company. The company’s financial performance reflects continued net losses, though operating losses narrowed significantly in 2025 compared to prior years. Liquidity remains moderate with a current ratio near 1.78. While its proprietary drug-delivery system underpins a narrow moat, the new solar analytics unit presents fresh growth opportunities albeit with execution risks as the company navigates this industry shift. Capital allocation is constrained by negative operating cash flow and minimal capital expenditures, with no dividends or buybacks reported.